Axogen provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include: Avance Nerve Graft, which is an off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector, which is a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; Axoguard Nerve Protector, which is a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.

CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products. The company's primary product and candidates in hematology/oncology include: EVOMELA (Melphalan for Injection), an intravenous formulation of melphalan commercialized in the multiple myeloma treatment setting in the United States; CNCT19, which targets CD19, a B-cell surface protein expressed during all phases of B-cell development and a validated target for B-cell driven hematological malignancies; CID-103, an investigational anti-CD38 monoclonal antibody being developed for the treatment of patients with multiple myeloma.

Century Bancorp is a bank holding company. Through its subsidiary, Century Bank and Trust Company, the company provides services to commercial enterprises, state and local governments and agencies, non-profit organizations and individuals. The company also provides securities brokerage services through a program called Investment Services at Century Bank, which is supported by LPL Financial, a third party securities brokerage business. The company grants single-family and multi-family residential loans, commercial and commercial real estate loans, municipal loans, and a variety of consumer loans. In addition, the company provides savings accounts, NOW accounts, demand deposits, time deposits and money market accounts.

FS KKR Capital is an externally managed, non-diversified, closed-end management investment company. The company is managed by FS/KKR Advisor, LLC, an investment adviser, which oversees the management of the company's operations. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans of private U.S. companies. The company may purchase interests in loans or make other debt investments, including investments in senior secured bonds, through secondary market transactions in the over-the-counter, market or directly from its target companies as primary market or directly originated investments.

International Flavors & Fragrances is a creator and manufacturer of taste, scent and complementary adjacent products, including cosmetic active and natural health ingredients. The company's operating segments are Taste and Scent. The Taste segment develops a range of different flavors and taste offerings for its customers, most of which are tailor-made. The company's Taste business is comprised of various portfolios across flavor compounds, savory solutions, inclusions and nutrition and specialty ingredients. The Scent segment creates fragrance compounds and fragrance ingredients for the household and personal care products. The company also produces cosmetic active and functional ingredients for use in cosmetics.

Motorcar Parts of America is a supplier of automotive aftermarket non-discretionary replacement parts and diagnostic equipment. The company's non-discretionary replacement parts are sold to automotive retail chain stores and warehouse distributors throughout North America and to main automobile manufacturers for both their aftermarket programs and warranty replacement programs. The company's hard parts portfolio includes: rotating electrical products such as alternators and starters, wheel hub assemblies and bearings, and brake master cylinders. The company's diagnostic equipment portfolio includes: bench top alternator and starter testing, production alternator and starter, and alternator and starter endurance.

National HealthCare is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The company's business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. The company has a non-controlling ownership interest in a hospice care business that services the company-owned health care centers and others. In addition, the company provides management services, accounting and financial services, as well as insurance services to third party operators of health care facilities.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Prospect Capital is a financial services company that primarily lends to and invests in middle market privately-held companies. The company is a closed-end investment company. The company's investment objective is to generate both income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies in need of capital for acquisitions, divestitures, growth, development, recapitalizations and other purposes.

RiceBran Technologies is an ingredient company serving food, animal nutrition and specialty markets focused on processing and marketing of healthy, natural and nutrient dense products derived from raw rice bran, an underutilized by-product of the rice milling industry. The company converts raw rice bran into various products including: stabilized rice bran (SRB); RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and its family of ProRyza products, which includes derivatives composed of protein and protein/fiber blends.